
Sign up to save your podcasts
Or


Host Jennifer Caudel, DO welcomes Jay Shubrook, DO, Director of Clinical Research and Diabetes Services at Touro University-California College of Osteopathic Medicine. Recorded on site at the American Osteopathic Association's annual medical education conference, Dr. Shubrook discusses a pilot study in which newly diagnosed type 2 diabetes patients were treated with early insulin rather than lifestyle changes and oral therapies alone. The results suggested not only good safety profiles, but also better long-term outcomes for patients.
Dr. Brian McDonough welcomes Dr. Marcy Lake, faculty member of the Kaiser Permanente Family Medicine Residency Program in Portland Oregon and author of a recent article in American Family Physician devoted to disorders of the pituitary gland. Their discussion tours diagnostic considerations toward the workup of pituitary diseases, and emerging treatment paradigms for clinicians at general, endocrinology, and surgical levels of care.
Candis M Morello, Professor of Clinical Pharmacy at UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, joins Dr. John Russell to talk about team-based care integrations of certified diabetes educators to help empower diabetes patients and improve long-term outcomes.
Diabetes Discourse, a non-certified educational series, is brought to you by AstraZeneca, pushing the boundaries of science to create life-changing medicines for people with diabetes. Content of this diabetes education is produced and solely controlled by ReachMD. This series is intended for healthcare professionals only.
Brought to you by
Host Dr. John Russell welcomes Candis M. Morello, PharmD., CDE, FCSHP, Professor of Clinical Pharmacy and Associate Dean for Student Affairs at the Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Morello explains the importance of patient education, communication, and motivation needed to instill a positive and healthy approach to diabetes care.
Diabetes Discourse, a non-certified educational series, is brought to you by AstraZeneca, pushing the boundaries of science to create life-changing medicines for people with diabetes. Content of this diabetes education is produced and solely controlled by ReachMD. This series is intended for healthcare professionals only.
Brought to you by
For clinicians managing patients with T2DM, the clinical landscape for standards of care, diagnostic methods and techniques, and treatment options has become increasingly complex. Yet despite this challenge in keeping up to date with the latest recommendations, updated practice guidelines have also made it a point to emphasize "big picture" elements in diabetes care, reinforcing mainstays of treatment that can potentially get overlooked.
On this episode, Dr. John Russell welcomes diabetes expert Dr Neil Skolnik, Associate Director of Family Medicine at Abington Jefferson Health, to explore the "Back to Basics" model in diabetes management, with emphasis on individualized therapeutic approaches and lifestyle modification strategies for improving long-term patient outcomes.
Diabetes Discourse, a non-certified educational series, is brought to you by AstraZeneca, pushing the boundaries of science to create life-changing medicines for people with diabetes. Content of this diabetes education is produced and solely controlled by ReachMD. This series is intended for healthcare professionals only.
Brought to you by
In this edition of The Pharmacy Report®, host Dr. Linda Bernstein spotlights type 1 diabetes and the new paradigms of research in disease detection, prevention and treatment. In the Movers and Shakers segment, Dr. Stephen E. Gitelman, M.D., Professor of Clinical Pediatrics and Chair of Pediatric Diabetes and Clinical Research at the University of California, San Francisco shares his fascinating path of discovery and research into this complex disease and how someday it could revolutionize therapeutic approaches for not just the patient, but at-risk family members as well.
References mentioned in this segment:
Highlights from ENDO, the 95th Annual Meeting of The Endocrine Society. The Endocrine Society is the world's oldest, largest, and most active organization devoted to research on hormones and the clinical practice of endocrinology. Download the program to hear global thought leaders discuss the newest and exciting presentation at this year's meeting.
Diabetes Diagnosis and Management is presented by The Endocrine Society and its Hormone Health Network. This annual workshop focuses on current issues in clinical diabetes management and provides state-of-the art updates. The complete Diabetes Diagnosis and Management recording is free on endosessions.org. To hear more from ENDO 2013, visit endosessions.org
Program HighlightsHost Dr. Farhad Zangeneh welcomes Paresh Dandona MD, PhD, Professor and Chief of Endocrinology in the Department of Medicine at the University of Buffalo. His Specialty and Research Focus are in Endocrinology, Diabetes and Metabolism. He is also the Founder & Medical Director of the Diabetes-Endocrinology Center of Western New York. In this program, Dr. Dandona will be discussing insulin induced cardioprotection, inflammatory and oxidative stress in acute myocardial infarction. He will also review hyperglycemia and cardiotoxicity in acute myocardial infarction. Please take a listen!
What are the sources of glucose in the body? Is diabetes a pancreatic disease or a hepatic disease? What is the importance of glucose toxicity in Type 1 or Type 2 diabetes patients? To answer these questions and many more, join our host Dr. Farhad Zangenh in a discussion with Dr. Robert Rizza, an authority in the regulation of carbohydrate metabolism in humans, and the Executive Dean for Research at Mayo Clinic. Download the podcast and listen in!
In diabetes management, clinicians typically measure glycemic control with fasting plasma glucose (FPG) and premeal glucose measurements, and HbA1c. And, the goals for each of these measurements have been established based on the results of many clinical trials. However, the majority of patients with diabetes fail to achieve these glycemic goals. Elevated postprandial glucose (PPG) concentrations may contribute to suboptimal glycemic control. Host Dr Farhad Zangeneh is joined by Dr. Paul Jellinger who will address the issue of postprandial glucose and its complications.
Paul S. Jellinger, MD and Master of the American College of Endocrinology (MACE) serves as Professor of Medicine on the voluntary faculty at the University of Miami and served as Chief of the Section of Endocrinology at Memorial Regional Hospital in Hollywood, Florida. Dr. Jellinger served as president of the AACE, the ACE and the Florida Endocrine Society. Dr. Jellinger has been active on the AACE Board of Directors.